SCHEMBL22889274

SCHEMBL22889274

c1ccc(-c2ccc3ccc(-c4ccc5cccc(-c6nc(-c7ccc(-c8ccccc8)c8ccccc78)nc(-c7cccc8c7oc7ccccc78)n6)c5c4)cc3c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.43
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
PIM1 P11309 1/20 0.37
CSNK2A2 P19784 1/20 0.37
CSNK2B P67870 1/20 0.37
PIM3 Q86V86 1/20 0.37
PIM2 Q9P1W9 1/20 0.37
GGPS1 O95749 1/20 0.36
PLA2G2A P14555 3/20 0.36
PLA2G4A P47712 3/20 0.36
ALDH1A1 P00352 4/20 0.35
MAPT P10636 3/20 0.35
KDM4E B2RXH2 3/20 0.35
HSD17B10 Q99714 3/20 0.35
HPGD P15428 2/20 0.35
TSHR P16473 2/20 0.35
TP53 P04637 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22889427 0.98 ALOX5 (0.44) ALOX5CA12CA1CA2CA9
SCHEMBL22889428 0.97 ALOX5 (0.43) ALOX5CA12CA1CA2CA9
SCHEMBL21304729 0.97 ALOX5 (0.45) ALOX5CA12CA1CA2CA9
SCHEMBL21304731 0.96 ALOX5 (0.46) ALOX5CA12CA1CA2CA9
SCHEMBL22889127 0.96 ALOX5 (0.42) ALOX5CA12CA1CA2CA9
SCHEMBL22888614 0.96 ALOX5 (0.44) ALOX5CA12CA1CA2CA9
SCHEMBL22889125 0.95 ALOX5 (0.43) ALOX5CA12CA1CA2CA9
SCHEMBL22888615 0.95 ALOX5 (0.45) ALOX5CA12CA1CA2CA9
SCHEMBL22889128 0.94 ALOX5 (0.43) ALOX5CA12CA1CA2CA9
SCHEMBL22889402 0.94 ALOX5 (0.49) ALOX5CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO.,LTD. (JP) 2021-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, RPS4Y1, AR ALOX5 3163/4885CA12 3436/4885CA1 3265/4885
US-11765972-B2 Compound and organic electroluminescence device using the same AR, OR10J3, RPS4Y1 ALOX5 3071/4885CA12 3561/4885CA1 3393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.